Company Snapshot
- Ticker
- ILMN
- Name
- ILMN
- Sector
- None
- Currency
- 0
- Relative Volume
- None
- Market Cap
- 21039720000.000000
- Volume
- 1,700,293
- Avg Volume (3M)
- 1,660,830
ILMN
ILMN
Last update recent
134.87
-1.57
(-1.15%)
Market Cap
21039720000.000000
Dividend Yield
0.00%
1Y Return
None%
Beta
None
Price & Moving Averages
Interactive chart with SMA overlays and intraday breadth.
Profitability
- Revenue
- 4287000000.000000
- EPS
- 4.47
- Dividend / Share
- None
- Total Dividends
- $0.00
- Dividend Yield
- 0.0%
- Net Income
- 703000000.000000
- Net Margin
- 16.4%
- Payout Ratio
- 0.0%
- Qtly Growth YoY
- None
Valuation & Quality
- P/E
- 29.93
- Forward P/E
- None
- P/S
- 4.91
- P/B
- 8.84
- Beta
- None
- Debt / Equity
- 1.08
- Current Ratio
- 1.43
- Return on Equity
- 0.30%
- Return on Assets
- 0.11%
Technicals & Returns
- Distance vs 200 DMA
- 40.81%
- 200 DMA
- 95.78
- Distance vs 50 DMA
- 18.14%
- 50 DMA
- 114.16
- Return 1Y
- None%
- Return YTD
- None%
- Beta (Trailing)
- None
- Relative Volume
- None
Factor Lens
Plot valuation, momentum, or volume trends.
Seasonal Performance
Company Overview
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements, as well as cancer detection testing services. Its customers inclu Read more
- Name
- ILMN
- Industry
- Medical - Diagnostics & Research
- CEO
- Mr. Jacob Thaysen Ph.D.
- Employees
- 10,590
- IPO Date
- 2000-07-28
- Phone
- 858 202 4500
- Address
- None
- Website
- https://www.illumina.com
Dividend Yield
0.00%
TTM Distributions
$0.00
Latest News
Curated headlines from premium sources.
Why Illumina (ILMN) is a Top Momentum Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Daiwa Securities Group Inc. Has $6.80 Million Holdings in Illumina, Inc. $ILMN
Daiwa Securities Group Inc. grew its holdings in Illumina, Inc. (NASDAQ: ILMN) by 10.7% during the second quarter, according to its most recent filing with the…
Illumina and MyOme Strike Collaboration Deal Including Strategic Investment to Support MyOme's Clinical Trial That Could Save U.S. Healthcare $200 Billion Annually
Partnership unites Illumina's leading sequencing technology with cutting-edge clinical genomics analyses and AI to advance precision medicine for early detecti…
Bet on These 3 Stocks With Upgraded Broker Ratings Amid Uncertainties
Illumina, Commercial Metals and Newmont have all seen broker upgrades, signaling bullish momentum amid market uncertainties.
Federated Hermes Inc. Has $76.55 Million Holdings in Illumina, Inc. $ILMN
Federated Hermes Inc. trimmed its stake in shares of Illumina, Inc. (NASDAQ: ILMN) by 0.5% during the second quarter, according to its most recent disclosure w…
Brown Advisory Inc. Has $69.27 Million Stock Holdings in Illumina, Inc. $ILMN
Brown Advisory Inc. decreased its position in Illumina, Inc. (NASDAQ: ILMN) by 75.0% during the undefined quarter, according to the company in its most recent …